Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	341.59	86.49	19.59
Graham Fair Price	-69.13	2.35	7.60
PEG	10113.79	1.93	-0.02
Price/Book	37.19	3.15	2.29
Price/Cash Flow	514.92	-47.14	7.67
Prices/Earnings	1046.78	-213.83	18.65
Price/Sales	90.64	3.40	1.78
Price/FCF	514.92	-47.14	7.67
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.94	0.38	0.39
Operating Margin	-99.65	< 0.005	0.05
ROA	-87.17	< 0.005	< 0.005
ROE	0.03	< 0.005	-88.04
ROIC	0.02	< 0.005	-99.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	0.08	-83.71
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	38.29	-1.00	-97.39
EPS QOQ	9.86	-1.11	-88.77
FCF QOQ	5.69	-1.23	-78.42
Revenue QOQ	0.34	-0.27	-22.37
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.08	102.96	44.85
Days Sales Outstanding (DSO)	30.44	30.58	0.47
Inventory Turnover	1.27	0.87	-30.96
Debt/Capitalization	0.31	0.31	-0.51
Quick Ratio	1.03	0.96	-6.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9.14	8.15	-10.76
Cash	9.94	8.38	-15.78
Capex	-0.45	-0.20	55.05
Free Cash Flow	2.73	-0.54	-80.09
Revenue	11.77	7.56	-35.78
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.49	1.53	2.70
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.80	-5.12	-82.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating